Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
Scan to Download
One powerful score. Smarter investment decisions.
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
Log in
Start for free
Search
Start for free
Markets
/
Stocks
/
vrdn
/
Viridian Therapeutics Inc
VRDN
Add to Watchlist
19.890
USD
+0.010
+0.05%
Close 07-30 16:00(ET)
Quotes delayed by 15 min
19.900
USD
+19.900
After-hours 07/30, 20:00 (ET)
2.04B
Market Cap
Loss
P/E TTM
Viridian Therapeutics Inc
19.890
+0.010
+0.05%
Overview
Financials
Discussions
Analysis
Company
Profile
Revenue
Shareholders
Corporate
Overview
Financials
Discussions
Analysis
Company
Profile
Revenue
Shareholders
Corporate
Shareholding Stats
Updated: Sun, May 10
Updated: Sun, May 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Fidelity Management & Research Company LLC
11.24%
BlackRock Institutional Trust Company, N.A.
5.03%
Deep Track Capital LP
4.91%
Bellevue Asset Management AG
3.95%
Vanguard Capital Management, LLC
3.77%
Other
71.10%
Shareholders
Shareholders
Proportion
Fidelity Management & Research Company LLC
11.24%
BlackRock Institutional Trust Company, N.A.
5.03%
Deep Track Capital LP
4.91%
Bellevue Asset Management AG
3.95%
Vanguard Capital Management, LLC
3.77%
Other
71.10%
Shareholder Types
Shareholders
Proportion
Investment Advisor
41.90%
Hedge Fund
24.54%
Investment Advisor/Hedge Fund
21.23%
Venture Capital
7.32%
Research Firm
3.87%
Private Equity
2.76%
Pension Fund
0.67%
Bank and Trust
0.37%
Sovereign Wealth Fund
0.11%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
443
116.15M
112.73%
+6.60M
2025Q4
385
99.38M
104.13%
-8.40M
2025Q3
368
96.50M
101.72%
-9.82M
2025Q2
368
94.63M
115.87%
-12.44M
2025Q1
387
93.96M
114.21%
-15.28M
2024Q4
381
93.18M
114.36%
-9.55M
2024Q3
354
88.84M
112.43%
+6.26M
2024Q2
331
71.47M
112.09%
-12.60M
2024Q1
329
71.87M
114.62%
-2.66M
2023Q4
309
61.41M
117.06%
+4.73M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Fidelity Management & Research Company LLC
12.41M
12.15%
+1.51M
+13.89%
Dec 31, 2025
BlackRock Institutional Trust Company, N.A.
5.55M
5.43%
+826.64K
+17.49%
Dec 31, 2025
Deep Track Capital LP
2.52M
2.47%
-2.86M
-53.07%
Dec 31, 2025
Bellevue Asset Management AG
4.36M
4.26%
+4.36M
+155506.10%
Dec 31, 2025
Fairmount Funds Management LLC
3.91M
3.83%
--
--
Dec 31, 2025
VR Adviser, LLC
3.88M
3.8%
--
--
Dec 31, 2025
State Street Investment Management (US)
3.47M
3.39%
+912.39K
+35.72%
Dec 31, 2025
T. Rowe Price Associates, Inc.
3.36M
3.28%
+1.01M
+43.17%
Dec 31, 2025
Perceptive Advisors LLC
3.04M
2.98%
+1.58M
+108.06%
Dec 31, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Simplify Propel Opportunities ETF
3.62%
Virtus LifeSci Biotech Clinical Trials ETF
1.02%
ALPS Medical Breakthroughs ETF
0.82%
State Street SPDR S&P Biotech ETF
0.6%
JPMorgan Healthcare Leaders ETF
0.49%
First Trust Small Cap Growth AlphaDEX Fund
0.43%
iShares Micro-Cap ETF
0.32%
Direxion Daily S&P Biotech Bull 3X Shares
0.24%
JPMorgan BetaBuilders US Small Cap Equity ETF
0.1%
ProShares Hedge Replication ETF
0.09%
View more
Simplify Propel Opportunities ETF
Proportion
3.62%
Virtus LifeSci Biotech Clinical Trials ETF
Proportion
1.02%
ALPS Medical Breakthroughs ETF
Proportion
0.82%
State Street SPDR S&P Biotech ETF
Proportion
0.6%
JPMorgan Healthcare Leaders ETF
Proportion
0.49%
First Trust Small Cap Growth AlphaDEX Fund
Proportion
0.43%
iShares Micro-Cap ETF
Proportion
0.32%
Direxion Daily S&P Biotech Bull 3X Shares
Proportion
0.24%
JPMorgan BetaBuilders US Small Cap Equity ETF
Proportion
0.1%
ProShares Hedge Replication ETF
Proportion
0.09%